SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-22-000969
Filing Date
2022-02-15
Accepted
2022-02-14 18:26:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 rocksprings-fprx123121a1.htm SC 13G/A 108021
  Complete submission text file 0001172661-22-000969.txt   109660
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS, INC. (Subject) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87623 | Film No.: 22635875
SIC: 2834 Pharmaceutical Preparations

Mailing Address 650 SOUTH EXETER STREET SUITE 1070 BALTIMORE MD 21202
Business Address 650 SOUTH EXETER STREET SUITE 1070 BALTIMORE MD 21202 4102200129
Rock Springs Capital Management LP (Filed by) CIK: 0001595725 (see all company filings)

IRS No.: 800944416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A